<!DOCTYPE html>

<html lang="en" data-theme="light">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>NSAIDs & Antipyretics - Essentials of Medical Pharmacology</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap"
        rel="stylesheet">

    <link rel="stylesheet" href="../styles/main.css">

    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\\(', '\\)']],
                displayMath: [['$$', '$$'], ['\\[', '\\]']],
                processEscapes: true,
                processEnvironments: true
            },
            svg: { fontCache: 'global' },
            options: {
                skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
            }
        };
    </script>

    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

</head>

<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Floating TOC -->

    <nav class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span> Table of Contents
        </div>
        <ul class="floating-toc-list">
            <li><a href="#introduction">Overview & Mechanism</a></li>
            <li><a href="#salicylates">Salicylates (Aspirin)</a></li>
            <li><a href="#paracetamol">Paracetamol</a></li>
            <li><a href="#traditional-nsaids">Traditional NSAIDs</a></li>
            <li><a href="#cox-2-inhibitors">COX-2 Inhibitors</a></li>
            <li><a href="#adverse-effects">Shared Toxicities</a></li>
            <li><a href="#choice">Choice of Drug</a></li>
            <li><a href="#case-study">Case Study</a></li>
        </ul>
    </nav>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üíä</span>
                        <span>Topic 15</span>
                    </div>
                    <h1 class="document-title">Nonsteroidal Antiinflammatory Drugs and Antipyretic-Analgesics</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Autacoids and Related Drugs</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>45 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Introduction -->
                    <section class="content-section" id="introduction">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üîë</span>
                                Overview & Mechanism
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>NSAIDs (Nonsteroidal Antiinflammatory Drugs) are a class of drugs that have analgesic,
                                antipyretic, and antiinflammatory actions. Unlike morphine, they do not depress the CNS,
                                do not produce physical dependence, have no abuse liability, and are particularly
                                effective in inflammatory pain.</p>

                            <h3>Mechanism of Action</h3>
                            <p>The major mechanism is the inhibition of <strong>Cyclooxygenase (COX)</strong>, the
                                enzyme responsible for the biosynthesis of prostaglandins (PGs), prostacyclin ($PGI_2$),
                                and thromboxane ($TXA_2$) from arachidonic acid.</p>
                            <ul>
                                <li><strong>Aspirin:</strong> Inhibits COX irreversibly by acetylating a serine residue.
                                </li>
                                <li><strong>Other NSAIDs:</strong> Act as competitive and reversible inhibitors.</li>
                            </ul>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Beneficial Actions of PG Inhibition</h4>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><strong>Analgesia:</strong> Prevents sensitization of
                                            nerve endings by PGs (peripheral action) and raises pain threshold in CNS.
                                        </li>
                                        <li class="list-item"><strong>Antipyresis:</strong> Resets hypothalamic
                                            thermostat to normal by blocking $PGE_2$ production induced by pyrogens
                                            (cytokines).</li>
                                        <li class="list-item"><strong>Antiinflammatory:</strong> Suppresses signs of
                                            inflammation (pain, swelling, vasodilatation) mainly by inhibiting COX-2.
                                        </li>
                                        <li class="list-item"><strong>Antithrombotic:</strong> Inhibits platelet
                                            aggregation (mainly Aspirin).</li>
                                        <li class="list-item"><strong>Closure of ductus arteriosus:</strong> In
                                            newborns.</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 2: Salicylates -->
                    <section class="content-section" id="salicylates">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Salicylates: Aspirin
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Aspirin (Acetylsalicylic acid) is rapidly converted in the body to salicylic acid. It is
                                the prototype NSAID.</p>

                            <h3>Pharmacological Actions</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Analgesic:</strong> Effective in low doses (0.3-0.6 g) for
                                    inflammatory, tissue injury related, connective tissue, and integumental pain.
                                    Weaker than opioids.</li>
                                <li class="list-item"><strong>Antipyretic:</strong> Resets thermostat, promotes heat
                                    loss via sweating and cutaneous vasodilatation.</li>
                                <li class="list-item"><strong>Antiinflammatory:</strong> Requires high doses (3-6
                                    g/day).</li>
                                <li class="list-item"><strong>Blood:</strong> Irreversibly inhibits platelet COX-1,
                                    blocking $TXA_2$ synthesis. Antiplatelet effect lasts for the life of the platelet
                                    (~7 days). Prolongs bleeding time.</li>
                                <li class="list-item"><strong>Metabolic:</strong> High doses increase cellular
                                    metabolism (uncoupling of oxidative phosphorylation), stimulate respiration
                                    (respiratory alkalosis), followed by respiratory depression (acidosis) in toxicity.
                                </li>
                            </ul>

                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ò£Ô∏è</span>
                                    <h4 class="callout-title">Acute Salicylate Poisoning</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Fatal dose: 15-30 g in adults.</p>
                                    <p><strong>Manifestations:</strong> Vomiting, dehydration, electrolyte imbalance,
                                        acidotic breathing, restlessness, delirium, hallucinations, hyperpyrexia,
                                        convulsions, coma, death due to respiratory failure.</p>
                                    <p><strong>Treatment:</strong> Symptomatic and supportive. External cooling, i.v.
                                        fluids with $Na^+$, $K^+$, $HCO_3^-$, and glucose. Alkaline diuresis enhances
                                        excretion.</p>
                                </div>
                            </div>

                            <h3>Precautions & Contraindications</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Peptic ulcer/Bleeding tendencies:</strong>
                                    Contraindicated.</li>
                                <li class="list-item"><strong>Children:</strong> Contraindicated in viral infections
                                    (chicken pox, influenza) due to risk of <strong>Reye's syndrome</strong> (hepatic
                                    encephalopathy).</li>
                                <li class="list-item"><strong>Pregnancy:</strong> Avoid near term (delayed labour,
                                    postpartum haemorrhage, premature closure of ductus).</li>
                                <li class="list-item"><strong>Surgery:</strong> Stop 1 week before elective surgery.
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 3: Paracetamol -->
                    <section class="content-section" id="paracetamol">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõ°Ô∏è</span>
                                Para-amino phenol Derivatives: Paracetamol
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Paracetamol (Acetaminophen)</strong> has analgesic and antipyretic actions
                                similar to aspirin but has <strong>negligible antiinflammatory action</strong>.</p>

                            <h3>Mechanism</h3>
                            <p>It is a poor inhibitor of PG synthesis in peripheral tissues (hence poor antiinflammatory
                                effect) but more active on COX in the brain. It may inhibit a splice variant COX-3 in
                                the brain. It does not stimulate respiration, affect acid-base balance, cause gastric
                                irritation, or affect platelet function.</p>

                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Acute Paracetamol Poisoning</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Occurs with large doses (>10 g in adults). Mechanism: Depletion of glutathione
                                        leads to accumulation of the toxic metabolite
                                        <strong>N-acetyl-p-benzoquinoneimine (NABQI)</strong> which binds covalently to
                                        liver proteins causing <strong>centrilobular hepatic necrosis</strong>.</p>
                                    <p><strong>Specific Antidote:</strong> <strong>N-acetylcysteine</strong>
                                        (replenishes glutathione). Most effective if given early (<16 hours).</p>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 4: Traditional NSAIDs -->
                    <section class="content-section" id="traditional-nsaids">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Traditional NSAIDs
                            </h2>
                        </div>

                        <div class="content-card">
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Class/Drug</th>
                                            <th>Key Features</th>
                                            <th>Common Uses</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Propionic Acid Derivatives</strong><br>(Ibuprofen, Naproxen)
                                            </td>
                                            <td>Better tolerated than aspirin. Ibuprofen is safer; Naproxen is longer
                                                acting and potent.</td>
                                            <td>Rheumatoid/Osteoarthritis, soft tissue injuries, dental pain,
                                                dysmenorrhoea.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Acetic Acid Derivatives</strong><br>(Ketorolac, Indomethacin)
                                            </td>
                                            <td><strong>Ketorolac:</strong> Potent analgesic (comparable to morphine in
                                                post-op pain), modest
                                                antiinflammatory.<br><strong>Indomethacin:</strong> Potent
                                                antiinflammatory but high toxicity (CNS, GI).</td>
                                            <td>Ketorolac: Post-op/dental pain (short term).<br>Indomethacin: Acute
                                                gout, ankylosing spondylitis.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Fenamates</strong><br>(Mefenamic acid)</td>
                                            <td>Analgesic, weaker antiinflammatory.</td>
                                            <td>Muscle/joint pain, dysmenorrhoea.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Enolic Acid Derivatives</strong><br>(Piroxicam)</td>
                                            <td>Long acting ($t_{1/2}$ ~2 days), potent antiinflammatory.</td>
                                            <td>Chronic arthritic conditions (single daily dose).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Diclofenac</strong></td>
                                            <td>Analgesic-antipyretic-antiinflammatory. Accumulates in synovial fluid.
                                            </td>
                                            <td>Widely used for arthritis, bursitis, toothache, renal colic.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>

                    <!-- Section 5: COX-2 Inhibitors -->
                    <section class="content-section" id="cox-2-inhibitors">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üéØ</span>
                                COX-2 Inhibitors
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Developed to inhibit COX-2 (inflammation) without affecting COX-1 ("house keeping"
                                functions like gastric protection and haemostasis). They cause less gastric mucosal
                                damage.</p>

                            <h3>Classification</h3>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Preferential COX-2 Inhibitors</h4>
                                    <ul>
                                        <li>Nimesulide</li>
                                        <li>Diclofenac</li>
                                        <li>Aceclofenac</li>
                                        <li>Meloxicam</li>
                                        <li>Etodolac</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Selective COX-2 Inhibitors (Coxibs)</h4>
                                    <ul>
                                        <li>Celecoxib</li>
                                        <li>Etoricoxib</li>
                                        <li>Parecoxib (Injectable)</li>
                                    </ul>
                                </div>
                            </div>

                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">üíî</span>
                                    <h4 class="callout-title">Cardiovascular Risk</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Selective COX-2 inhibitors reduce endothelial $PGI_2$
                                        (vasodilator/anti-aggregatory) production without affecting platelet $TXA_2$
                                        (pro-aggregatory/vasoconstrictor). This imbalance exerts a <strong>prothrombotic
                                            influence</strong>, increasing the risk of myocardial infarction and stroke.
                                        They should be avoided in patients with history of ischaemic heart
                                        disease/hypertension.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 6: Adverse Effects -->
                    <section class="content-section" id="adverse-effects">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö†Ô∏è</span>
                                Shared Toxicities of NSAIDs
                            </h2>
                        </div>

                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Gastrointestinal:</strong> Nausea, gastric irritation,
                                    erosions, peptic ulceration, bleeding (due to inhibition of protective PGs). Lowest
                                    with Paracetamol and COX-2 inhibitors.</li>
                                <li class="list-item"><strong>Renal:</strong> $Na^+$ and water retention, edema, chronic
                                    renal failure, analgesic nephropathy (inhibition of renal vasodilator PGs).</li>
                                <li class="list-item"><strong>Cardiovascular:</strong> Rise in BP, risk of MI/stroke
                                    (especially with COX-2 inhibitors and Diclofenac).</li>
                                <li class="list-item"><strong>Haematological:</strong> Bleeding (inhibition of platelet
                                    aggregation).</li>
                                <li class="list-item"><strong>Hypersensitivity:</strong> Rashes, pruritus, angioedema,
                                    asthma exacerbation (aspirin-sensitive asthma).</li>
                                <li class="list-item"><strong>Pregnancy:</strong> Prolongation of labour, premature
                                    closure of ductus arteriosus.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 7: Choice of Drug -->
                    <section class="content-section" id="choice">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚úÖ</span>
                                Choice of NSAID
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Choice is often empirical, based on individual response and risk factors.</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Condition</th>
                                            <th>Preferred Choice</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Mild-to-moderate pain (little inflammation)</strong></td>
                                            <td>Paracetamol or low-dose Ibuprofen.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Acute musculoskeletal/dental pain</strong></td>
                                            <td>Diclofenac, Ibuprofen, Ketorolac.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Rheumatoid arthritis / Acute Gout</strong></td>
                                            <td>Naproxen, Piroxicam, Indomethacin, high dose Aspirin.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Gastric intolerance / High ulcer risk</strong></td>
                                            <td>Selective COX-2 inhibitor or Paracetamol (often with PPI).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>CV Risk (IHD, Hypertension)</strong></td>
                                            <td>Avoid COX-2 inhibitors. Use Naproxen or low-dose Aspirin/Ibuprofen.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Paediatric patients</strong></td>
                                            <td>Paracetamol, Ibuprofen. <strong>Avoid Aspirin</strong> (Reye's
                                                syndrome).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Pregnancy</strong></td>
                                            <td>Paracetamol is safest.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>

                    <!-- Section 8: Case Study -->
                    <section class="content-section" id="case-study">
                        <div class="section-header">
                            <div class="section-number">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§î</span>
                                Problem Directed Study
                            </h2>
                        </div>

                        <div class="content-card">
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <h4 class="callout-title">Case 14.1</h4>
                                </div>
                                <div class="callout-content">
                                    <p>A 65-year-old lady with osteoarthritis of the knee and a history of heart attack
                                        (treated with angioplasty/stent 1 year ago) is taking aspirin 75 mg daily.</p>
                                    <p><strong>(a) Suitable Analgesic:</strong> <strong>Paracetamol</strong> (up to
                                        4g/day) is the first choice for osteoarthritis, especially given her cardiac
                                        history. If insufficient, <strong>Naproxen</strong> is considered the safest
                                        NSAID regarding cardiovascular risk.</p>
                                    <p><strong>(b) To be Avoided:</strong> <strong>Selective COX-2 inhibitors</strong>
                                        (Etoricoxib, Celecoxib) and <strong>Diclofenac</strong> should be avoided due to
                                        increased risk of thrombotic cardiovascular events (MI/stroke), which is
                                        dangerous for a patient with history of MI.</p>
                                    <p><strong>(c) Topical Medication:</strong> Yes, <strong>topical NSAIDs</strong>
                                        (Diclofenac gel, etc.) can be helpful. They provide local relief with minimal
                                        systemic absorption, thus reducing the risk of systemic side effects
                                        (gastric/CV).</p>
                                </div>
                            </div>
                        </div>
                    </section>

                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="topic-14-prostaglandins.html"
                            class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Prostaglandins & Eicosanoids</div>
                        </a>

                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>15</span>
                                <span class="progress-separator">/</span>
                                <span>20</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 75%;"></div>
                            </div>
                            <div class="progress-label">Topic Progress</div>
                        </div>

                        <a href="topic-16-rheumatoid-gout.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Antirheumatoid & Antigout</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="../js/theme.js"></script>

    <script src="../js/navigation.js"></script>

    <script src="../js/interactions.js"></script>

</body>

</html>